Joseph Miller
Director of Finance/CFO at AURINIA PHARMACEUTICALS INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Joseph M.
Miller is currently the Chief Financial Officer at Aurinia Pharmaceuticals, Inc. He previously worked as the Senior Director-Accounting at Qiagen Genomics, Inc. from 2006 to 2015.
From 2018 to 2022, he served as the Director at Avalo Therapeutics, Inc. Prior to that, he was the Vice President-Finance at Sucampo Pharmaceuticals LLC from 2015 to 2018.
Mr. Miller also held the position of Chief Financial Officer & Vice President-Finance at Eppendorf-5 Prime, Inc. from 2002 to 2006.
He obtained his undergraduate degree from Villanova University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-05 | 495,928 ( 0.34% ) | 2 M $ | 2024-03-30 |
Joseph Miller active positions
| Companies | Position | Start |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Director of Finance/CFO | 2020-04-26 |
Former positions of Joseph Miller
| Companies | Position | End |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Director of Finance/CFO | 2020-04-23 |
| SUCAMPO PHARMACEUTICALS, INC. | Director of Finance/CFO | 2018-03-31 |
Qiagen Genomics, Inc.
 Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen Genomics, Inc. provides research and technology in the bioscience area. The company is headquartered in Bothell, WA. | Comptroller/Controller/Auditor | 2014-12-31 |
| Eppendorf-5 Prime, Inc. | Director of Finance/CFO | 2005-12-31 |
Training of Joseph Miller
| Villanova University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AVALO THERAPEUTICS, INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Private companies | 3 |
|---|---|
Qiagen Genomics, Inc.
Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen Genomics, Inc. provides research and technology in the bioscience area. The company is headquartered in Bothell, WA. | Commercial Services |
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
| Eppendorf-5 Prime, Inc. |
- Stock Market
- Insiders
- Joseph Miller
